HPTX Related Analyst Comments

Feb 26, 2013 09:06 AM Needham & Company Maintains Buy on Hyperion Therapeutics (HPTX) Post Q4

Feb 4, 2013 03:12 PM Needham & Company Raises PT on Hyperion Therapeutics (HPTX) to $25 after FDA Approval for Ravicti